Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers

AIM: TMC114 is a new HIV protease inhibitor, used in combination with low-dose ritonavir (TMC114/r) as a pharmacokinetic enhancer. Tenofovir disoproxil fumarate (TDF) is a nucleotide reverse transcriptase inhibitor. Both antiretrovirals show activity against wild-type and resistant HIV. An open-labe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hoetelmans, Richard M W, Mariën, Kris, De Pauw, Martine, Hill, Andrew, Peeters, Monika, Sekar, Vanitha, De Doncker, Piet, Woodfall, Brian, Lefebvre, Eric
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2007
Teme:
Drug Interactions
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2203266/
https://ncbi.nlm.nih.gov/pubmed/17610528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2007.02957.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items